Latest Insider Transactions at Myriad Genetics Inc (MYGN)
This section provides a real-time view of insider transactions for Myriad Genetics Inc (MYGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYRIAD GENETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYRIAD GENETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,543
-1.11%
|
$81,774
$18.41 P/Share
|
|
Sep 26
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.31%
|
$2,394
$18.41 P/Share
|
|
Sep 26
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,293
-0.96%
|
$41,274
$18.41 P/Share
|
|
Sep 26
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,950
-1.21%
|
$53,100
$18.41 P/Share
|
|
Sep 26
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.98%
|
$15,516
$18.41 P/Share
|
|
Sep 25
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,662
-0.92%
|
$29,916
$18.69 P/Share
|
|
Sep 25
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,263
-1.26%
|
$94,734
$18.69 P/Share
|
|
Sep 25
2022
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
345
-0.79%
|
$6,210
$18.69 P/Share
|
|
Sep 25
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,793
-1.16%
|
$50,274
$18.69 P/Share
|
|
Sep 25
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
642
-0.26%
|
$11,556
$18.69 P/Share
|
|
Sep 25
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-0.39%
|
$6,228
$18.69 P/Share
|
|
Sep 21
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-0.29%
|
$14,040
$20.2 P/Share
|
|
Aug 25
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,031
-0.42%
|
$24,744
$24.89 P/Share
|
|
Aug 25
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,056
-0.73%
|
$73,344
$24.89 P/Share
|
|
Aug 25
2022
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.87%
|
$5,280
$24.89 P/Share
|
|
Aug 25
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-0.46%
|
$27,168
$24.89 P/Share
|
|
Aug 25
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-0.63%
|
$27,504
$24.89 P/Share
|
|
Aug 15
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
2,150
-0.51%
|
-
|
|
Aug 13
2022
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
72,350
-3.16%
|
$1,953,450
$27.61 P/Share
|
|
Jun 09
2022
|
Jayne B. Hart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,036
+0.56%
|
$14,504
$14.84 P/Share
|
|
Jun 06
2022
|
Daniel K Spiegelman Director |
SELL
Open market or private sale
|
Direct |
6,424
-15.9%
|
$122,056
$19.25 P/Share
|
|
Jun 02
2022
|
Heinrich Dreismann Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+14.63%
|
-
|
|
Jun 02
2022
|
Colleen F Reitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+23.04%
|
-
|
|
Jun 02
2022
|
Daniel Skovronsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+23.85%
|
-
|
|
Jun 02
2022
|
Lee Nisley Newcomer Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+23.04%
|
-
|
|
Jun 02
2022
|
S. Louise Phanstiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+15.14%
|
-
|
|
Jun 02
2022
|
Daniel K Spiegelman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+29.95%
|
-
|
|
Jun 02
2022
|
Rashmi Kumar Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+24.22%
|
-
|
|
Jun 02
2022
|
Dennis Langer Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,275
+13.92%
|
-
|
|
Apr 14
2022
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.95%
|
-
|
|
Apr 14
2022
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+14.62%
|
-
|
|
Apr 01
2022
|
Eric Santa Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,976
-2.52%
|
$74,400
$25.88 P/Share
|
|
Mar 24
2022
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,084
-1.85%
|
$1,102,100
$25.32 P/Share
|
|
Mar 24
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,956
-1.05%
|
$223,900
$25.32 P/Share
|
|
Mar 24
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,347
-1.07%
|
$133,675
$25.32 P/Share
|
|
Mar 24
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,641
-0.99%
|
$91,025
$25.32 P/Share
|
|
Mar 24
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,666
-0.57%
|
$66,650
$25.32 P/Share
|
|
Mar 24
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,842
-1.57%
|
$71,050
$25.32 P/Share
|
|
Mar 22
2022
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
173,144
+12.58%
|
-
|
|
Mar 22
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,866
+7.89%
|
-
|
|
Mar 22
2022
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+7.54%
|
-
|
|
Mar 22
2022
|
Nicole Lambert Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,665
+11.81%
|
-
|
|
Mar 22
2022
|
Jayne B. Hart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+9.41%
|
-
|
|
Mar 22
2022
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+17.44%
|
-
|
|
Mar 22
2022
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
9,754
+20.79%
|
-
|
|
Mar 22
2022
|
Eric Santa Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+24.37%
|
-
|
|
Mar 22
2022
|
Pamela Wong Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,353
+22.86%
|
-
|
|
Feb 28
2022
|
Jayne B. Hart Officer |
SELL
Open market or private sale
|
Direct |
10,500
-3.06%
|
$262,500
$25.0 P/Share
|
|
Feb 28
2022
|
Jayne B. Hart Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+2.96%
|
$241,500
$23.98 P/Share
|
|
Feb 25
2022
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,594
-8.65%
|
$62,256
$24.69 P/Share
|